hydroxyindoleacetic acid has been researched along with Brain Atrophy, Circumscribed Lobar in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurihara, M | 2 |
| Komatsu, H | 2 |
| Sengoku, R | 2 |
| Shibukawa, M | 2 |
| Morimoto, S | 2 |
| Matsubara, T | 2 |
| Arakawa, A | 2 |
| Orita, M | 2 |
| Ishibashi, K | 2 |
| Mitsutake, A | 2 |
| Shibata, S | 2 |
| Ishiura, H | 2 |
| Adachi, K | 2 |
| Ohse, K | 2 |
| Hatano, K | 2 |
| Ihara, R | 2 |
| Higashihara, M | 2 |
| Nishina, Y | 2 |
| Tokumaru, AM | 2 |
| Ishii, K | 2 |
| Saito, Y | 2 |
| Murayama, S | 2 |
| Kanemaru, K | 2 |
| Iwata, A | 2 |
1 other study available for hydroxyindoleacetic acid and Brain Atrophy, Circumscribed Lobar
| Article | Year |
|---|---|
CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Frontotemporal Dementia; Humans; Hydroxyindole | 2023 |
CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Frontotemporal Dementia; Humans; Hydroxyindole | 2023 |
CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Frontotemporal Dementia; Humans; Hydroxyindole | 2023 |
CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Frontotemporal Dementia; Humans; Hydroxyindole | 2023 |